Deerfield Management Company »

Revolution Medicines shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Revolution Medicines shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $252M 200M 1.26

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Brookdale Sr Living Note 3.500%10/1 (Principal)
Revolution Medicines (RVMD)
Praxis Precision Medicines I Com New (PRAX)
Viatris (VTRS)
Centene Corporation (CNC)
Revolution Medicines Note 0.500% 5/0 (Principal)
United Therapeutics Corporation (UTHR)
Arrowhead Pharmaceuticals In Note 1/1 (Principal)
Legend Biotech Corp Sponsored Ads (LEGN)
Cogent Biosciences (COGT)
Genmab A/s Sponsored Ads (GMAB)
Brookdale Senior Living (BKD)
Vera Therapeutics Cl A (VERA)
Ionis Pharmaceuticals (IONS)

View all positions for Deerfield Management Company

Top funds holding Revolution Medicines

Deerfield Management Company
Calamos Advisors
MacKay Shields
Linden Advisors
Zazove Associates
Jpmorgan Chase & Co
M&G
Ameriprise Financial
Franklin Resources
SSI Investment Management
Toronto-Dominion Bank
Millennium Management
FMR
Advent Capital Management
Nicholas Investments Partners

View all funds holding Revolution Medicines